The hexosamine biosynthesis pathway is a targetable liability in KRAS/LKB1 mutant lung cancer
2020 · Nature Metabolism · 137 citations
https://doi.org/10.1038/s42255-020-00316-0
A
Akash Kaushik
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.1K
Citations
12
h-index
13
i10-index
Akash Kaushik is an academic researcher from The University of Texas Southwestern Medical Center. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & Cancer, Lipids, and Metabolism & Metabolism, Diabetes, and Cancer. The author has an h-index of 12, co-authored 45 publications.
ORCID: 0000-0002-8200-2370Papers by this author
worksMetabolic diversity within breast cancer brain-tropic cells determines metastatic fitness
2022 · Cell Metabolism · 96 citations
https://doi.org/10.1016/j.cmet.2021.12.001
In vivo isotope tracing reveals a requirement for the electron transport chain in glucose and glutamine metabolism by tumors
2022 · Science Advances · 65 citations
https://doi.org/10.1126/sciadv.abn9550
A renal cell carcinoma tumorgraft platform to advance precision medicine
2021 · Cell Reports · 52 citations
https://doi.org/10.1016/j.celrep.2021.110055
The hexosamine biosynthesis pathway is a targetable liability in lung cancers with concurrent KRAS and LKB1 mutations
2020 · bioRxiv (Cold Spring Harbor Laboratory) · 2 citations
https://doi.org/10.1101/2020.04.13.039669
Optimized protocol for stable isotope tracing and steady-state metabolomics in mouse HER2+ breast cancer brain metastasis
2022 · STAR Protocols · 1 citations
https://doi.org/10.1016/j.xpro.2022.101345
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat